| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Schimmel Paul serves as a Director at ATYR and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 33 buys and 5 sells. Those positions are worth an estimated $387K at current prices.
Historically, Schimmel Paul's trades have earned a middling insider score of 53/100 across 8 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +30.1%.
The biggest single holding is ATYR (~$387K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 2,912,114 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2026 | ATYR Atyr Pharma, Inc. | Director | Buy | 100,000 | $0.50 | $49,630.00 | +14.7% | +19.2% | - | |
| Oct 9, 2025 | ATYR Atyr Pharma Inc | Director | Buy | 1,000,000 | $0.91 | $911,801.16 | +242.1% | -21.7% | -74.2% | |
| Jul 24, 2024 | ATYR Atyr Pharma Inc | Director | Buy | 100,000 | $1.85 | $184,613.40 | +31.9% | +73.6% | +187.8% | |
| May 10, 2023 | ATYR Atyr Pharma Inc | Director | Buy | 200,000 | $2.25 | $450,000.00 | +177.0% | -13.3% | -23.9% | |
| Sep 20, 2021 | ATYR Atyr Pharma Inc | Director | Buy | 250,000 | $8.00 | $2,000,000.00 | +8,651% | -22.3% | -71.3% | |
| May 18, 2021 | ATYR Atyr Pharma Inc | Director | Buy | 50,000 | $3.98 | $199,000.00 | +79.3% | +18.4% | -24.2% | |
| May 20, 2020 | ATYR Atyr Pharma Inc | Director | Sell | 8,447 | $3.64 | $30,738.63 | -1.9% | - | - | |
| Feb 10, 2020 | ATYR Atyr Pharma Inc | Director | Buy | 254,000 | $4.25 | $1,079,500.00 | +138.4% | - | - | |
| Nov 26, 2018 | ATYR Atyr Pharma Inc | Director | Buy | 147,225 | $0.54 | $79,795.95 | +20.0% | - | - | |
| Sep 4, 2018 | ATYR Atyr Pharma Inc | Director | Buy | 42,749 | $0.74 | $31,461.07 | +6.2% | - | - |